Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Hand Dermatoses

quinazolines has been researched along with Hand Dermatoses in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Gao, Y; Lian, WY; Wang, YG; Yang, CQ1
Inoue, A; Nakamura, M; Nishio, D; Sawada, Y1
Descourt, R; Misery, L; Roguedas, AM; Rouxel, AM1
Afifi, Y; Benomar, S; Bouhllab, J; Boutayeb, S; Errihanni, H; Hamada, S; Hassam, B1
Kenner-Bell, BM; Lacouture, ME; Paller, AS1
Berg, A; Brustugun, OT; Helland, Å; Lund-Iversen, M1
Rebandel, P; Rudzki, E1

Reviews

1 review(s) available for quinazolines and Hand Dermatoses

ArticleYear
Pyogenic granuloma caused by afatinib: Case report and review of the literature.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:1

    Topics: Afatinib; Aged; Antineoplastic Agents; Female; Fingers; Granuloma, Pyogenic; Hand Dermatoses; Humans; Quinazolines

2017

Other Studies

6 other study(ies) available for quinazolines and Hand Dermatoses

ArticleYear
[Research progress in pharmacology and toxicology of evodiamine].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2021, Volume: 46, Issue:20

    Topics: Evodia; Hand Dermatoses; Humans; Plant Extracts; Quinazolines; Tinea

2021
[Hand-foot syndrome: A new side effect of erlotinib].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:11

    Topics: Aged; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Erythema; Foot Dermatoses; Foot Diseases; Hand Dermatoses; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines; Syndrome

2008
Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.
    Dermatology online journal, 2009, Nov-15, Volume: 15, Issue:11

    Topics: Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dermatitis, Seborrheic; Disease Progression; Drug Eruptions; Erlotinib Hydrochloride; Facial Dermatoses; Follow-Up Studies; Hand Dermatoses; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Risk Assessment; Syndrome

2009
Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma.
    Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:2

    Topics: Adult; ErbB Receptors; Erlotinib Hydrochloride; Female; Hand Dermatoses; Humans; Keratoderma, Palmoplantar; Protein Kinase Inhibitors; Quinazolines

2010
Palmar bullous blistering induced by erlotinib.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:5

    Topics: Adenocarcinoma; Blister; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Hand Dermatoses; Humans; Lung Neoplasms; Middle Aged; Mutation; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome

2011
Contact sensitivity to quinazoline oxide.
    Contact dermatitis, 2001, Volume: 44, Issue:1

    Topics: Adult; Allergens; Dermatitis, Allergic Contact; Dermatitis, Occupational; Drug Industry; Facial Dermatoses; Female; Hand Dermatoses; Humans; Occupational Exposure; Patch Tests; Quinazolines

2001